메뉴 건너뛰기
Journal of Clinical Neuromuscular Disease
Volumn 7, Issue 1, 2005, Pages 25-28
A cautionary tale: The risks of flecainide treatment for myotonic dystrophy
Author keywords

Arrhythmia; Flecainide; Myotonia
Indexed keywords

ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; ENCAINIDE; FLECAINIDE; MEXILETINE; PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT; TOCAINIDE;
EID: 24344447272     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cnd.0000174372.19888.41     Document Type: Article
Times cited : (3)
References (7)
  • 1
    • 0033549032 scopus 로고    scopus 로고
    • A 10-year study of mortality in a cohort of patients with myotonic dystrophy
    • Mathieu J, Allard P, Potvin L, et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52:1658-1662.
    • (1999) Neurology , vol.52 , pp. 1658-1662
    • Mathieu, J.1    Allard, P.2    Potvin, L.3
  • 2
    • 0032897169 scopus 로고    scopus 로고
    • Functional consequences of a domain 1/S6 segment sodium channel mutation associated with painful congenital myotonia
    • Wang DW, VanDeCarr D, Ruben PC, et al. Functional consequences of a domain 1/S6 segment sodium channel mutation associated with painful congenital myotonia. FEBS Lett. 1999;448:231-234.
    • (1999) FEBS Lett , vol.448 , pp. 231-234
    • Wang, D.W.1    Vandecarr, D.2    Ruben, P.C.3
  • 3
    • 0026011647 scopus 로고
    • Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial
    • Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.
    • (1991) N Engl J Med , vol.324 , pp. 781-788
    • Echt, D.S.1    Liebson, P.R.2    Mitchell, L.B.3
  • 4
    • 0033818531 scopus 로고    scopus 로고
    • Microvascular ischemia in patients with myotonic dystrophy
    • Itoh H, Shimizu M, Horita Y, et al. Microvascular ischemia in patients with myotonic dystrophy. Jpn Circ J. 2000;64:720-722.
    • (2000) Jpn Circ J , vol.64 , pp. 720-722
    • Itoh, H.1    Shimizu, M.2    Horita, Y.3
  • 5
    • 0036898687 scopus 로고    scopus 로고
    • Myotonic dystrophy and the heart
    • Pelargonio G, Dello RA, Sanna T, et al. Myotonic dystrophy and the heart. Heart. 2002;88:665-670.
    • (2002) Heart , vol.88 , pp. 665-670
    • Pelargonio, G.1    Dello, R.A.2    Sanna, T.3
  • 6
    • 0033514985 scopus 로고    scopus 로고
    • Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy
    • Lazarus A, Varin J, Ounnoughene Z, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation. 1999;99:1041-1046.
    • (1999) Circulation , vol.99 , pp. 1041-1046
    • Lazarus, A.1    Varin, J.2    Ounnoughene, Z.3
  • 7
    • 0034821285 scopus 로고    scopus 로고
    • Does cytosinethymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
    • Clarke NR, Kelion AD, Nixon J, et al. Does cytosinethymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart. 2001;86:411-416.
    • (2001) Heart , vol.86 , pp. 411-416
    • Clarke, N.R.1    Kelion, A.D.2    Nixon, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.